Marcos Couto

9PUBLICATIONS
16CO-AUTHORS
Catalysis and mechanisms of reactionsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 09, 2026
Solvents Promote Selective TEDA2+. Formation Driven through a Pnicogen Bond in Selectfluor.

|May 15, 2026
Corrigendum: Nuclear-Targeted Boron-Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma.

|Mar 16, 2026
Nuclear-Targeted Boron-Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma.

Marcos Couto, Martina Buschittari, Marina Carpano

|Nov 27, 2025
Structure-Activity Relationships of closo- and nido-Carborane Erlotinib Analogs: Lipophilicity as a Key Modulator of Anti-Glioma Activity.

Belén Dávila, Pablo Vignolo, Martina Silvarrey

|Nov 03, 2025
Escaping from Flatland: 3D Carborane-Based Bioisosteres of Erlotinib as Potential Anticancer Agents.

Belén Dávila, Pablo Vignolo, Ignacio González

|Apr 26, 2025
Enhancing Boron Neutron Capture Therapy (BNCT) with Materials Based on COSAN-Functionalized Nanoparticles.

Albert Ferrer-Ugalde, Amanda Muñoz-Juan, Anna Laromaine

Pageof 2

Frequent Collaborators

6 joint publications

Hugo Cerecetto

2 joint publications

Mauricio Cabrera

2 joint publications

Francesc Teixidor

2 joint publications

Clara Viñas